Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: Comparative pharmacoeconomic analyses

Annals of Nutrition and Metabolism

Volumn 59, Issue SUPPL. 1, 2011, Pages 44-52

  Spieldenner, Jörg ^a   Belli, Dominique ^b   Dupont, Christophe ^c   Haschke, Ferdinand ^a   Iskedjian, Michael ^d,e,f   Nevot Falcó, Santiago ^g   Szajewska, Hania ^h   Von Berg, Andrea ⁱ  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d PharmIdeas Research and Consulting Inc   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f PharmIdeas Europe SAS   (France)

^g Althaia   (Spain)

^h MEDICAL UNIVERSITY OF WARSAW   (Poland)

ⁱ Marien Hospital   (Germany)

Author keywords

Allergy prevention; Atopic dermatitis; Cost effectiveness analysis; Cost minimization analysis; Infant formula; Infant nutrition

Indexed keywords

ARTICLE; ARTIFICIAL MILK; ATOPIC DERMATITIS; BREAST FEEDING; COST EFFECTIVENESS ANALYSIS; DENMARK; FRANCE; GERMANY; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MILK; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SPAIN; SWITZERLAND; WHEY;

COST SAVINGS; DERMATITIS, ATOPIC; EUROPE; HUMANS; HYDROLYSIS; INFANT; INFANT FORMULA; INFANT, NEWBORN; MILK PROTEINS; PROTEIN HYDROLYSATES; RISK FACTORS;

EID: 84455209556     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000334232     Document Type: Article

References (42)

1. 44-52 1 Spergel J, Paller A: Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112:S118-S127. (Pubitemid 37550028)
2. Lewis-Jones S: Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006; 60: 984-992. (Pubitemid 44082290)
3. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, ISAAC Phase Three Study Group: Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009; 124: 1251.e23-1258.e23.
4. Schultz Larsen F, Diepgen T, Svensson A: The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 1996; 34: 760-764. (Pubitemid 26137199)
5. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG: The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994; 30: 35-39. (Pubitemid 24033816)
6. Asher M, Montefort S, Björkstén B, et al: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743. (Pubitemid 44279052)
7. Fennessy M, Coupland S, Popay J, Naysmith K: The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research. J Epidemiol Community Health 2000; 54: 581-589. (Pubitemid 30460013)
8. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR, International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups: Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008; 121: 947-954.
9. Böhme M, Wickman M, Lennart Nordvall S, Svartengren M, Wahlgren CF: Family history and risk of atopic dermatitis in children up to 4 years. Clin Exp Allergy 2003; 33: 1226-1231. (Pubitemid 37108526)
10. World Health Organization and United Nations Children's Fund: Global Strategy for Infant and Young Child Feeding. Geneva, NLM Classification WS 120 (2003). http://www.who.int (accessed Sep 16, 2011).
11. European Network for Public Health Nutrition: Networking, Monitoring, Intervention and Training. Infant and young child feeding:standard recommendations for the European Union [http://printfu.org/read/infant-and- young-child-feeding-standardre c ommend ations-for-the-bb16.html?f=1qeYpurpn 6Wih-SUpOGunK2nh7Xd3Mbi3IXR4M2O7dXq28yM0t7O4MyF1tfO0t3U3KeF3- PX09jJ19SS29PX1eLaytrT19nd19Pjks-d5obp1cqMnaSTlqPYqqSjkOjal6jYpqCnn5bS2uPm 1t7EttrZyo6q6Z-loofWlKThrpqtp4fU4-rVrpeU5- ngnOfa3tnR0d2k1ObPlNXg0Nrd2d2cydvS6ZTZ3dPl5tfT6JTl0cuOqvM (accessed Sep 16, 2011)].
12. Société Française de Dermatologie: Prise en charge de la dermatite atopique de l'enfant. Texte des recommandations. Ann Dermatol Venereol 2005; 132: 1S9-1S18.
13. Muche-Borowski C, Kopp M, Reese I, et al: Allergieprävention. AWMF Guideline Register 061/16, 2009.
14. Lasarte Velillas J: Recomendaciones para la lactancia materna. Comité de Lactancia Materna de la Asociación Española de Pediatría (http://www.aeped.es/sites/default/files/lacmat-espanol.pdf).
15. Høst A, Koletzko B, Dreborg S, et al: Dietary products used in infants for treatment and prevention of food allergy. Joint statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology and Nutrition (ESPGHAN) Committee on Nutrition. Arch Dis Child 1999; 81: 80-84. (Pubitemid 29307465)
16. Halken S, Høst A, Hansen LG, Osterballe O: Effect of an allergy prevention programme on incidence of atopic symptoms in infancy. A prospective study of 159 'high-risk' infants. Allergy 1992; 47: 545-553.
17. Høst A, Halken S, Muraro A, et al: Dietary prevention of allergic diseases in infants and small children. Pediatr Allergy Immunol 2008; 19: 1-4.
18. Iskedjian M, Dupont C, Spieldenner J, Kanny G, Raynaud F, Farah B, Haschke F: Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children. Curr Med Res Opin 2010; 26: 2607-2626.
19. von Berg A, Koletzko S, Filipiak-Pittroff B, et al: The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol 2003; 111: 533-540. (Pubitemid 36337874)
20. von Berg A, Filipiak-Pittroff B, Krämer U, et al: Preventative effect of hydrolyzed formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008; 121: 1442-1447. (Pubitemid 351787357)
21. Alexander DD, Cabana MD: Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a metaanalysis. J Pediatr Gastroenterol Nutr 2010;50: 422-430.
22. Szajewska H, Horvath A: Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin 2010; 26: 423-437.
23. Iskedjian M, Szajewska H, Spieldenner J, Farah B, Berbari J: Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis. Curr Med Res Opin 2010; 26: 2599-2606.
24. Emerson RM, Williams HC, Allen BR: What is the cost of atopic dermatitis in preschool children? Br J Dermatol 2001; 144: 514-522. (Pubitemid 32232005)
25. Ricci G, Bendandi B, Pagliara L, et al: Atopic dermatitis in Italian children: evaluation of its economic impact. J Pediatr Health Care 2006; 20: 312-315.
26. Weinmann S, Kamtsiuris P, Wickman H, et al: The costs of atopy and asthma in children: assessment of direct costs and their determinants in a birth cohort. Pediatr Allergy Immunol 2003; 14: 18-26. (Pubitemid 36603985)
27. Su JC, Kemp AS, Varigos GA, Nolan TM: Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997; 76: 159-162. (Pubitemid 27086890)
28. Kemp AS: Atopic eczema: its social and financial costs. J Paediatr Child Health 1999; 35: 229-231. (Pubitemid 29282268)
29. Verboom P, Hakkaart-Van L, Sturkenboom M, De Zeeuw R, Menke H, Rutten F: The cost of atopic dermatitis in the Netherlands: an international comparison. Br J Dermatol 2002; 147: 716-724. (Pubitemid 35286157)
30. Ehlken B, Möhrenschlager M, Kugland B, Berger K, Quednau K, Ring J: Cost-of-illness study in patients suffering from atopic eczema in Germany. Hautarzt 2005; 56: 1144-1151. (Pubitemid 41719564)
31. Herd RM, Tidman MJ, Prescott RJ, Hunter JA: The cost of atopic eczema. Br J Dermatol 1996; 135: 20-23. (Pubitemid 26225109)
32. Berger ML (ed): Health Care Cost, Quality and Outcomes: ISPOR Book of Terms. Lawrenceville, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 2003.
33. Venturini F, Johnson KA: Introduction to pharmacoeconomic principles and application in pharmacy practice. CJHP 2002; 14: 6-15.
34. Iskedjian M, von Berg A, Bauer CP, et al: Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among German children: preliminary results (abstracts and poster). Sorrento, 44th Annual Meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition, May 25-28, 2011.
35. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Spanish children. Vevey, Nestlé Nutrition Institute, 2011.
36. Iskedjian M, Berbari J, Navarro V, Farah B, Detzel P, Spieldenner J: Pharmacoeconomic analyses of partially hydrolyzed infant formulas in prevention of atopic dermatitis: comparative results from 5 European countries (poster). Madrid, 14th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research, November 2011.
37. Spieldenner J, Belli D, Farah B, et al: Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children: preliminary results (poster). Newcastle, 52nd Annual Meeting of the European Society for Paediatric Research, October 16, 2011.
38. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish children. Vevey, Nestlé Nutrition Institute, 2011.
39. Mertens J, Stock S, Lungen M, et al: Is prevention of atopic eczema with hydrolyzed formulas cost-effective? An application of results of the GINI-study to the German situtation. Pediatr Res 2010;(suppl 1):66-67.Copenhagen, Oral presentation at the 3rd EAPS Congress, October 2010.
40. Baehler P, Baenziger O, Belli D, et al: Empfehlungen für die Säuglingsernährung 2009. Paediatrica 2009; 20: 13-15.
41. Chouraqui J-P, Dupont A, Bocquet A, et al: Alimentation des premiers mois de vie et prevention de l'allergie. Arch Pédiatr 2008; 15: 431-442.
42. Host A, Halken S, Muraro A, et al: Dietary prevention of allergic diseases in infants and small children. Amendment to previous published articles in Pediatric Allergy and Immunology 2004, by an expert group set up by the Section on Pediatrics, European Academy of Allergology and Clinical Immunology. Pediatr Allergy Immunol 2008; 19: 1-4.